FDA Inspection 829270 — Novo Nordisk A/S - 25A-B

Novo Nordisk A/S - 25A-B — FEI 3003131673

The FDA completed an inspection of Novo Nordisk A/S - 25A-B on Mar 19, 2013 in Hillerod. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 19, 2013
Fiscal Year
2013
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Hillerod (Denmark)

Citations

IDCFRDescription
313021 CFR 820.100(a)Lack of or inadequate procedures
367621 CFR 820.30(f)Design verification - documentation